2024-04-02 19:00:11 ET
Image source: The Motley Fool.
Ocugen (NASDAQ: OCGN)
Q4 2023 Earnings Call
Apr 02, 2024 , 8:30 a.m. ET
Operator
For further details see:
Ocugen (OCGN) Q4 2023 Earnings Call Transcript2024-04-02 19:00:11 ET
Image source: The Motley Fool.
Ocugen (NASDAQ: OCGN)
Q4 2023 Earnings Call
Apr 02, 2024 , 8:30 a.m. ET
Operator
For further details see:
Ocugen (OCGN) Q4 2023 Earnings Call TranscriptMarket Wire News is a media platform, the information on this page was provided by Motley Fool via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
• Initiated Phase 2 clinical trial MALVERN, Pa., July 25, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies and va...
2024-07-11 08:45:00 ET It hasn't been a stellar year so far for biotech companies. The industry, as measured by the SPDR S&P Biotech ETF , is up just 4% since January, significantly lagging the S&P 500 's nearly 17% gain. Of course, it's not hard to find stocks that have...